BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 11048557)

  • 1. [Treatment of severely delayed gastric emptying].
    Samsom M; Gooszen HG
    Ned Tijdschr Geneeskd; 2000 Oct; 144(41):1945-8. PubMed ID: 11048557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: The diagnosis and management of gastroparesis.
    Haans JJ; Masclee AA
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():37-46. PubMed ID: 18081647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis.
    Brown CK; Khanderia U
    Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prokinetics in patients with gastroparesis: a systematic analysis.
    Sturm A; Holtmann G; Goebell H; Gerken G
    Digestion; 1999; 60(5):422-7. PubMed ID: 10473966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.
    Onoma M; Yogo K; Ozaki K; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):35-42. PubMed ID: 18047625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic gastroparesis.
    Kong MF; Horowitz M
    Diabet Med; 2005 Sep; 22 Suppl 4():13-8. PubMed ID: 16109013
    [No Abstract]   [Full Text] [Related]  

  • 7. Gastroparesis: diagnosis and management.
    Horowitz M; Fraser RJ
    Scand J Gastroenterol Suppl; 1995; 213():7-16. PubMed ID: 8578243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of diabetic gastroparesis.
    Mukhopadhyay P; Basu AK
    J Indian Med Assoc; 2005 Mar; 103(3):184, 186. PubMed ID: 16173296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Domperidone is more effective than cisapride in children with diabetic gastroparesis.
    Franzese A; Borrelli O; Corrado G; Rea P; Di Nardo G; Grandinetti AL; Dito L; Cucchiara S
    Aliment Pharmacol Ther; 2002 May; 16(5):951-7. PubMed ID: 11966504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of gastric emptying and motility in diabetic gastroparesis with magnetic resonance imaging: effects of cisapride.
    Borovicka J; Lehmann R; Kunz P; Fraser R; Kreiss C; Crelier G; Boesiger P; Spinas GA; Fried M; Schwizer W
    Am J Gastroenterol; 1999 Oct; 94(10):2866-73. PubMed ID: 10520835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. a pilot study with cisapride as a model drug.
    Lehmann R; Honegger RA; Feinle C; Fried M; Spinas GA; Schwizer W
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):255-61. PubMed ID: 12951630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current pharmacological treatment of gastroparesis.
    Vandenplas Y; Hauser B; Salvatore S
    Expert Opin Pharmacother; 2004 Nov; 5(11):2251-4. PubMed ID: 15500371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroparesis and the current use of prokinetic drugs.
    Kendall BJ; McCallum RW
    Gastroenterologist; 1993 Jun; 1(2):107-14. PubMed ID: 8049884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double blind controlled trial of effect of cisapride on gastric emptying in diabetics.
    Dutta U; Padhy AK; Ahuja V; Sharma MP
    Trop Gastroenterol; 1999; 20(3):116-9. PubMed ID: 10695417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis.
    Mansi C; Borro P; Giacomini M; Biagini R; Mele MR; Pandolfo N; Savarino V
    Aliment Pharmacol Ther; 2000 May; 14(5):561-9. PubMed ID: 10792119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of Helicobacter pylori on symptom improvement with a prokinetic medication, cisapride, in patients with non-ulcer dyspepsia.
    Gonlachanvit S; Mahachai V; Chaiwatanarat T; Kullavanijaya P
    J Med Assoc Thai; 2005 May; 88(5):660-7. PubMed ID: 16149685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disorders of gastric emptying in diabetes. II. Treatment].
    Czambor-Ksiazek E; Pokrzywnicki W; Grzeszczak W; Duda G
    Wiad Lek; 1997; 50(1-3):39-41. PubMed ID: 9297356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of gastroparesis and functional dyspepsia after cisapride withdrawal].
    Louis H
    Rev Med Brux; 2012 Sep; 33(4):425-9. PubMed ID: 23091951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Domperidone versus metoclopramide in the treatment of diabetic gastroparesis.
    Dumitrascu DL; Weinbeck M
    Am J Gastroenterol; 2000 Jan; 95(1):316-7. PubMed ID: 10638616
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of EM574 and cisapride on gastric contractile and emptying activity in normal and drug-induced gastroparesis in dogs.
    Tanaka T; Mizumoto A; Mochiki E; Suzuki H; Itoh Z; Omura S
    J Pharmacol Exp Ther; 1998 Nov; 287(2):712-9. PubMed ID: 9808701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.